Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1Endocrine 1

Conditions

Carcinoma, Non-Small-Cell Lung 7Neoplasm Metastasis 5Small Cell Lung Carcinoma 4Ovarian Neoplasms 3Lung Neoplasms 3Breast Neoplasms 3Stomach Neoplasms 2Colonic Neoplasms 2Urinary Bladder Neoplasms 1Testicular Neoplasms 1Renal Insufficiency 1Pancreatic Neoplasms 1Neoplasms, Unknown Primary 1Melanoma 1Liver Failure 1Head and Neck Neoplasms 1Esophageal Neoplasms 1Endometrial Neoplasms 1Carcinoma, Transitional Cell 1Carcinoma, Small Cell 1Carcinoma, Neuroendocrine 1Brain Metastases From Non-small Cell Lung Cancer 1Adenocarcinoma, Bronchiolo-Alveolar 1Adenocarcinoma of Lung 1

Interventions

atezolizumab 4Nivolumab 4Cisplatin 4Topotecan 2Radiosurgery 2Paclitaxel 2Ipilimumab 2Immunoglobulin G 2Etoposide 2Disulfides 2veliparib 1tocilizumab 1repotrectinib 1pralsetinib 1pembrolizumab 1niraparib 1iadademstat 1durvalumab 1dostarlimab 1cabozantinib 1budigalimab 1berzosertib 1belinostat 1Temozolomide 1Specimen Handling 1Radiotherapy 1Podophyllotoxin 1Platinum 1Magnetic Resonance Spectroscopy 1Irinotecan 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Carcinoma, Neuroendocrine × veliparib × Thoracic × Clear all
NCT01642251 2023-05-06

Cisplatin and Etoposide With or Without Veliparib in Treating Patients With Extensive Stage Small Cell Lung Cancer

National Cancer Institute (NCI)

Phase 1/2 Completed
156 enrolled 13 charts
EndocrineThoracic

Carcinoma, Non-Small-Cell Lung, Carcinoma, Neuroendocrine, Carcinoma, Small Cell, Small Cell Lung Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡